Silo Pharma, Inc.
SILO
$0.45
$0.00-0.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | 1,280.00% | 0.00% | |||
| Gross Profit | -116.27% | 0.00% | |||
| SG&A Expenses | 10.46% | 6.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.67% | 13.89% | |||
| Operating Income | 7.78% | -14.12% | |||
| Income Before Tax | 7.80% | -16.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.80% | -16.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.80% | -16.76% | |||
| EBIT | 7.78% | -14.12% | |||
| EBITDA | 7.83% | -14.22% | |||
| EPS Basic | 37.96% | 16.61% | |||
| Normalized Basic EPS | 38.00% | 16.78% | |||
| EPS Diluted | 37.96% | 16.61% | |||
| Normalized Diluted EPS | 38.00% | 16.78% | |||
| Average Basic Shares Outstanding | 48.59% | 40.03% | |||
| Average Diluted Shares Outstanding | 48.59% | 40.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||